BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9541148)

  • 1. Psychopathological dimensions in schizophrenia: a correlational approach to items of the SANS and SAPS.
    Lin AS; Chen CH; Hwu HG; Lin HN; Chen JA
    Psychiatry Res; 1998 Feb; 77(2):121-30. PubMed ID: 9541148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive and negative symptoms in the psychoses: multidimensional scaling of SAPS and SANS items.
    Minas IH; Stuart GW; Klimidis S; Jackson HJ; Singh BS; Copolov DL
    Schizophr Res; 1992 Dec; 8(2):143-56. PubMed ID: 1457393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of positive and negative symptoms in schizophrenia.
    Malla AK; Norman RM; Williamson P
    Can J Psychiatry; 1993 Nov; 38(9):617-21. PubMed ID: 8306235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive and negative symptoms in neuroleptic-free psychotic inpatients.
    Stuart GW; Malone V; Currie J; Klimidis S; Minas IH
    Schizophr Res; 1995 Aug; 16(3):175-88. PubMed ID: 7488563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive and negative symptoms in the psychoses: multidimensional scaling of SAPS and SANS items.
    Moranville JT
    Schizophr Res; 1993 Oct; 10(3):277-8. PubMed ID: 8260447
    [No Abstract]   [Full Text] [Related]  

  • 6. Exploration of dimensions of psychopathology in neuroleptic-naïve patients with recent-onset schizophrenia/schizophreniform disorder.
    John JP; Khanna S; Thennarasu K; Reddy S
    Psychiatry Res; 2003 Nov; 121(1):11-20. PubMed ID: 14572620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The factor structure of schizophrenic symptoms: which model is supported by independent item analysis?].
    Ozel Kizil ET; Saka MC; Atbaşoğlu EC; Göğüş AK
    Turk Psikiyatri Derg; 2008; 19(2):141-8. PubMed ID: 18561046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive and negative symptoms in the psychoses. Re-analysis of published SAPS and SANS global ratings.
    Klimidis S; Stuart GW; Minas IH; Copolov DL; Singh BS
    Schizophr Res; 1993 Mar; 9(1):11-8. PubMed ID: 8461266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive and negative symptoms in the psychoses: principal components analysis of items from the Scale for the Assessment of Positive Symptoms and the Scale for the Assessment of Negative Symptoms.
    Minas IH; Klimidis S; Stuart GW; Copolov DL; Singh BS
    Compr Psychiatry; 1994; 35(2):135-44. PubMed ID: 8187478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive and negative symptoms in affected sib pairs with schizophrenia: implications for genetic studies in an African Xhosa sample.
    Niehaus DJ; Koen L; Laurent C; Muller J; Deleuze JF; Mallet J; Seller C; Jordaan E; Emsley R
    Schizophr Res; 2005 Nov; 79(2-3):239-49. PubMed ID: 15993564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimensional structure of psychotic symptoms: an item-level analysis of SAPS and SANS symptoms in psychotic disorders.
    Peralta V; Cuesta MJ
    Schizophr Res; 1999 Jul; 38(1):13-26. PubMed ID: 10427607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of cannabis abuse on schizophrenic psychopathology.
    Peralta V; Cuesta MJ
    Acta Psychiatr Scand; 1992 Feb; 85(2):127-30. PubMed ID: 1543037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical correlates of olfactory hallucinations in schizophrenia.
    Langdon R; McGuire J; Stevenson R; Catts SV
    Br J Clin Psychol; 2011 Jun; 50(2):145-63. PubMed ID: 21545448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three syndrome concept of schizophrenia. A factor analytic study.
    Malla AK; Norman RM; Williamson P; Cortese L; Diaz F
    Schizophr Res; 1993 Aug; 10(2):143-50. PubMed ID: 8398946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of positive and negative symptoms in first episode schizophrenia.
    Vázquez-Barquero JL; Lastra I; Cuesta Nuñez MJ; Herrera Castanedo S; Dunn G
    Br J Psychiatry; 1996 Jun; 168(6):693-701. PubMed ID: 8773811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Converting scores between the PANSS and SAPS/SANS beyond the positive/negative dichotomy.
    Grot S; Giguère CÉ; Smine S; Mongeau-Pérusse V; Nguyen DD; Preda A; Potvin S; van Erp TGM; Fbirn ; Orban P
    Psychiatry Res; 2021 Nov; 305():114199. PubMed ID: 34536695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alogia, attentional impairment, and inappropriate affect: their status in the dimensions of schizophrenia.
    Miller DD; Arndt S; Andreasen NC
    Compr Psychiatry; 1993; 34(4):221-6. PubMed ID: 8348799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptom structure in schizophrenia: two-, three- or four-factor models?
    Dollfus S; Everitt B
    Psychopathology; 1998; 31(3):120-30. PubMed ID: 9636941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subsyndromes of chronic schizophrenia: a phenomenological study.
    Arora A; Avasthi A; Kulhara P
    Acta Psychiatr Scand; 1997 Sep; 96(3):225-9. PubMed ID: 9296554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methods for assessing positive and negative symptoms.
    Andreasen NC
    Mod Probl Pharmacopsychiatry; 1990; 24():73-88. PubMed ID: 2336066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.